Clinicopathological predictive factors in the early remission of corticotroph pituitary macroadenomas in a tertiary referral centre

European Journal of Endocrinology
Przemysław WitekGrzegorz Kaminski

Abstract

Corticotroph macroadenomas are a rare cause of Cushing's disease (CD), but their properties are not well-recognised. The aim of this study was to evaluate the clinical and pathological aspects of corticotroph macroadenomas with particular emphasis on proliferation markers and their associations with the efficacy of surgical treatment. A prospective cohort study was conducted in a tertiary referral centre in Poland. In total, 59 patients with CD (20 macroadenomas and 39 microadenomas) were included in this study. Hormonal and imaging parameters, histopathological and ultrastructural features of the corticotroph tumours and the early surgical outcomes were evaluated. ACTH and ACTH/cortisol ratios were higher in macroadenomas (P<0.001 and P=0.002 respectively). Greater tumour volumes were associated with higher Ki-67 and p53 expression (Ptrend=0.009 and Ptrend=0.024 respectively) and the rates of sparsely granulated adenomas (Ptrend=0.036). Immediate postoperative remission and early biochemical remission rates were lower in macroadenomas compared to microadenomas (P<0.001). A logistic regression model showed that the immediate postoperative remission or early biochemical remission depended on tumour volume (P=0.005 and P=0.006 re...Continue Reading

References

Mar 20, 1998·European Journal of Endocrinology·P SelvaisD Maiter
Jan 27, 1999·The Journal of Clinical Endocrinology and Metabolism·P L Selvais, D M Maiter
Aug 29, 2003·European Journal of Endocrinology·S CannavòB Ambrosi
Dec 13, 2003·The Journal of Clinical Endocrinology and Metabolism·G ArnaldiM Boscaro
May 12, 2005·The Journal of Clinical Endocrinology and Metabolism·Y Sammy WooAshley B Grossman
Mar 3, 2006·Journal of Neurosurgery·Edward H Oldfield, Alexander O Vortmeyer
Aug 3, 2006·Neurosurgery·Bernd W ScheithauerEdward R Laws
Oct 5, 2007·Endocrine-related Cancer·Anne WierinckxJacqueline Trouillas
Mar 13, 2008·The Journal of Clinical Endocrinology and Metabolism·Lynnette K NiemanVictor M Montori
Apr 17, 2008·The Journal of Clinical Endocrinology and Metabolism·B M K BillerM Boscaro
May 21, 2010·Neurological Research·Paulo Henrique Pires de AguiarLaurence Katznelson
Jul 1, 2011·European Journal of Endocrinology·Elena ValassiUNKNOWN ERCUSYN Study Group
Jul 15, 2011·The American Journal of Surgical Pathology·Helen MadsenBette Kay Kleinschmidt-DeMasters
Mar 27, 2012·Human Pathology·Alberto RighiMaria P Foschini
Jun 16, 2012·Brain Pathology·Ozgur Mete, Sylvia L Asa
Oct 24, 2014·Endocrine Pathology·Kalman KovacsDavid G Munoz
Dec 17, 2014·Pituitary·Luis V SyroKalman Kovacs
Mar 1, 2015·Pituitary·Robert F DallapiazzaJohn A Jane
Jun 30, 2015·Environmental Toxicology and Chemistry·Amanda D HarwoodMichael J Lydy
Aug 20, 2015·Acta Neuropathologica Communications·Christian P MiermeisterRolf Buslei

❮ Previous
Next ❯

Software Mentioned

SPSS

Related Concepts

Related Feeds

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.